Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Brabec

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Journal of Medicinal Chemistry|August 1, 2022
Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium HomeostasisJakub Cervinka, Alberto Gobbo, Lorenzo Biancalana, et al.
Chemico-Biological Interactions|October 6, 2023
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activityGiulio Bresciani, Jakub Cervinka, Hana Kostrhunova, et al.
Angewandte Chemie (International Ed. in English)|August 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell DeathAmrita Sarkar, Vojtech Novohradsky, Moumita Maji, et al.
Journal of Medicinal Chemistry|July 21, 2006
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studiesYousef Najajreh, Elena Khazanov, Seba Jawbry, et al.
Journal of Inorganic Biochemistry|August 6, 2016
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and goldFlorian Schmitt, Kate Donnelly, Julienne K Muenzner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 28, 2021
DNA-Intercalative Platinum Anticancer Complexes Photoactivated by Visible LightHuayun Shi, Jana Kasparkova, Clément Soulié, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 19, 2017
Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of ActionVojtech Novohradsky, Jyoti Yellol, Olga Stuchlikova, et al.
Chemical Communications (Cambridge, England)|November 22, 2016
Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalizationJyoti Yellol, Sergio A Pérez, Gorakh Yellol, et al.
International Journal of Biological Macromolecules|February 11, 2016
New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compoundsOthman M Salem, Mária Vilková, Jana Janočková, et al.
Journal of Medicinal Chemistry|August 16, 2008
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenesTijana Bugarcic, Olga Nováková, Anna Halámiková, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Journal of Medicinal Chemistry|August 1, 2022
Ruthenium(II)-Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium HomeostasisJakub Cervinka, Alberto Gobbo, Lorenzo Biancalana, et al.
Chemico-Biological Interactions|October 6, 2023
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activityGiulio Bresciani, Jakub Cervinka, Hana Kostrhunova, et al.
Angewandte Chemie (International Ed. in English)|August 30, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell DeathAmrita Sarkar, Vojtech Novohradsky, Moumita Maji, et al.
Journal of Medicinal Chemistry|July 21, 2006
Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studiesYousef Najajreh, Elena Khazanov, Seba Jawbry, et al.
Journal of Inorganic Biochemistry|August 6, 2016
Effects of histidin-2-ylidene vs. imidazol-2-ylidene ligands on the anticancer and antivascular activity of complexes of ruthenium, iridium, platinum, and goldFlorian Schmitt, Kate Donnelly, Julienne K Muenzner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 28, 2021
DNA-Intercalative Platinum Anticancer Complexes Photoactivated by Visible LightHuayun Shi, Jana Kasparkova, Clément Soulié, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 19, 2017
Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of ActionVojtech Novohradsky, Jyoti Yellol, Olga Stuchlikova, et al.
Chemical Communications (Cambridge, England)|November 22, 2016
Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalizationJyoti Yellol, Sergio A Pérez, Gorakh Yellol, et al.
International Journal of Biological Macromolecules|February 11, 2016
New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compoundsOthman M Salem, Mária Vilková, Jana Janočková, et al.
Journal of Medicinal Chemistry|August 16, 2008
Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenesTijana Bugarcic, Olga Nováková, Anna Halámiková, et al.
Pageof 25